Cost-effective strategy to screen second primary colorectal cancers in cancer survivors

Jul 16, 2009

To suggest a feasible economic strategy for second primary colorectal cancer screening of cancer survivors in Korea, A research group constructed a decision-analytic model, compared cost-effectiveness results of cancer screening in male cancer survivors. All non-dominant strategies were those using colonoscopy in both cancer survivors and the general population, and more strict and frequent recommendation of colonoscopy, colonoscopy every 5 years and every 3 years, could be considered as economic strategies for male cancer survivors.

The recent improvement in survival due to early diagnosis and advances in treatment has raised the issue of second primary cancers in cancer survivors after their primary treatment. The age-standardized incidence rate was about 4 times higher for second primary (CRC) than for first primary CRC in Korea. However, until now, there have been few recommendations and economic evaluations of CRC screening for cancer survivors.

A research article to be published in the World Journal of Gastroenterology on July 7,2009 addresses this question To suggest a feasible economic strategy of second CRC screening for cancer survivors in Korea, authors constructed a decision-analytic model, and compared the cost-effectiveness results of cancer screening in male cancer survivors.

All non-dominated strategies were those using colonoscopy in both cancer survivors and the general population, and more strict and frequent recommendation of colonoscopy such as COL5 (screening every 5 years) and COL3 (screening every 3 years) could be considered as economic strategies for male cancer survivors.

The major barrier to promoting colonoscopy as a primary CRC screening tool is the lack of manpower to deliver colonoscopy to the public in Korea. In these human-resource limited settings, it is important to identify the most vulnerable population who has the most potential to receive the benefits. In younger cancer survivors aged 40 years old, COL5 might be economically feasible, while COL10 is usually recommended for the Korean general population aged 50 years old. Therefore, at least for cancer survivors, CRC screening should be covered by the Korean national health insurance scheme and methods using colonoscopy should be recommended as a primary screening strategy for CRC in this population.

More information: Park SM, Kim SY, Earle CC, Jeong SY, Yun YH. What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea? World J Gastroenterol 2009; 15(25): 3153-3160, www.wjgnet.com/1007-9327/15/3153.asp

Source: World Journal of Gastroenterology (/" rel="news">news : web)

Explore further: Increased risk for head, neck cancers in patients with diabetes

add to favorites email to friend print save as pdf

Related Stories

Study: Cancer survivors not getting needed tests

Jun 01, 2009

(AP) -- New research finds that people who had radiation treatments for cancer as children are less likely than the general public or even their healthy siblings to get recommended screening tests.

Family history and screening for colorectal cancer

Jun 09, 2008

A new study indicates that African Americans with a family history of colorectal cancer are less likely to be screened than African Americans at average risk for the disease. There is also some evidence to indicate that AA ...

Recommended for you

Incomplete HPV vaccination may offer some protection

3 hours ago

Minority women who received the Human Papillomavirus Vaccination (HPV) even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated. These findings appear in the journal ...

New imaging agent provides better picture of the gut

3 hours ago

A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time ...

User comments : 0